ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Liability in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q4 2024.
  • Elite Pharmaceuticals Inc /Nv/ Operating Lease, Liability for the quarter ending December 31, 2024 was $2.13M, a 8037% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $2.13M +$2.11M +8037% Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $2.16M +$2.16M +99926% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.27M +$2.26M +26308% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.37M +$2.37M +109415% Mar 31, 2024 10-K 2024-07-01
Q4 2023 $26.2K +$5.08K +24% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $2.16K -$25.1K -92.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $8.59K -$981K -99.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.16K -$1.04M -99.8% Mar 31, 2023 10-Q 2023-11-14
Q4 2022 $21.1K -$1.07M -98.1% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $27.2K -$1.12M -97.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $990K -$220K -18.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.04M +$812K +358% Mar 31, 2022 10-K 2022-06-29
Q4 2021 $1.09M +$866K +392% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $1.15M +$876K +321% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.21M $0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $227K -$148K -39.5% Mar 31, 2021 10-K 2021-06-14
Q4 2020 $221K -$204K -48% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $273K -$200K -42.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $1.21M +$689K +132% Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $375K -$225K -37.5% Mar 31, 2020 10-K 2020-06-30
Q4 2019 $425K Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $473K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $520K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $600K Apr 2, 2019 10-K 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.